12 hours agoLondon Biotechnology ShowFleet will be attending the London Biotechnology Show, taking place 8th and 9th May at Olympia. The London Biotechnology Show aims to be...
13 hours agoNavigating Challenges in the Development of ADA Assays for Immunogenicity StudiesIn the realm of biopharmaceutical development, understanding and mitigating the immunogenicity of therapeutic proteins is crucial for...
6 days agoFleet Bioprocessing re-certified to Cyber EssentialsFleet Bioprocessing has successfully been re-certified as meeting the standards of Cyber Essentials. Cyber Essentials is a Government...
Apr 5Choosing the Right Platform for ADA Assays in Immunogenicity Studies: A Critical DecisionIn the realm of biopharmaceutical development, understanding and mitigating the immunogenicity of therapeutic proteins is paramount....
Feb 26Streamlining Success: The Compelling Reasons to Outsource Bioconjugation and Antibody LabellingIn the dynamic landscape of life sciences and diagnostics, bioconjugation and antibody labelling stand as critical processes in advancing...
Jan 31Unlocking Efficiency: Reasons to Outsource Immunoassay and ELISA DevelopmentIn the rapidly evolving landscape of life sciences and diagnostics, immunoassays and ELISAs play a pivotal role in detecting and...